RETRACTED: Comprehensive review for non-coding RNAs: From mechanisms to therapeutic applications (Retracted article. See vol. 239, 2025)

被引:17
作者
Zhang, YanJun [1 ]
Zhan, Lijuan [1 ]
Jiang, Xue [1 ]
Tang, Xiaozhu [2 ]
机构
[1] Jiangsu Coll Nursing, Coll Pharm & Tradit Chinese Med, Huaian 223005, Jiangsu, Peoples R China
[2] Nanjing Univ Chinese Med, Sch Med & Holist Integrat Med, Nanjing 210023, Peoples R China
基金
中国国家自然科学基金;
关键词
Non-coding RNAs; Disease; Cancer; Biomarkers; Therapeutics; CIRCULAR RNA; EXTRACELLULAR VESICLES; CLINICAL-APPLICATION; POTENTIAL BIOMARKER; PROSTATE-CANCER; EMERGING ROLES; LUNG-CANCER; CELLS; EXOSOMES; MIR-155;
D O I
10.1016/j.bcp.2024.116218
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Non-coding RNAs (ncRNAs) are an assorted collection of transcripts that are not translated into proteins. Since their discovery, ncRNAs have gained prominence as crucial regulators of various biological functions across diverse cell types and tissues, and their abnormal functioning has been implicated in disease. Notably, extensive research has focused on the relationship between microRNAs (miRNAs) and human cancers, although other types of ncRNAs, such as long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs), are also emerging as significant contributors to human disease. In this review, we provide a comprehensive summary of our current knowledge regarding the roles of miRNAs, lncRNAs, and circRNAs in cancer and other major human diseases, particularly cancer, cardiovascular, neurological, and infectious diseases. Moreover, we discuss the potential utilization of ncRNAs as disease biomarkers and as targets for therapeutic interventions.
引用
收藏
页数:20
相关论文
共 308 条
[41]   A lung targeted miR-29 mimic as a therapy for pulmonary fibrosis [J].
Chioccioli, Maurizio ;
Roy, Subhadeep ;
Newell, Rachel ;
Pestano, Linda ;
Dickinson, Brent ;
Rigby, Kevin ;
Herazo-Maya, Jose ;
Jenkins, Gisli ;
Ian, Steward ;
Saini, Gauri ;
Johnson, Simon R. ;
Braybrooke, Rebecca ;
Yu, Guying ;
Sauler, Maor ;
Ahangari, Farida ;
Ding, Shuizi ;
DeIuliis, Joseph ;
Aurelien, Nachelle ;
Montgomery, Rusty L. ;
Kaminski, Naftali .
EBIOMEDICINE, 2022, 85
[42]   The Roles of Hypoxia-Inducible Factors and Non-Coding RNAs in Gastrointestinal Cancer [J].
Cho, Hyun-Soo ;
Han, Tae-Su ;
Hur, Keun ;
Ban, Hyun Seung .
GENES, 2019, 10 (12)
[43]   miR-31-3p functions as a tumor suppressor by directly targeting GABBR2 in prostate cancer [J].
Choi, Sujin ;
Lee, Soonchul ;
Han, Young-Hoon ;
Choi, Junwon ;
Kim, Isaac ;
Lee, Jusung ;
An, Hyun-Ju .
FRONTIERS IN ONCOLOGY, 2022, 12
[44]   THE ROLE OF microRNAs IN CARCINOGENESIS AND THE UTILITY OF microRNA DETERMINATION IN DIAGNOSIS OF GASTRIC CANCER DEVELOPMENT [J].
Cholewinski, G. ;
Waluga, M. .
JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2022, 73 (06) :689-697
[45]  
Choong Oi Kuan, 2017, Noncoding RNA Res, V2, P100, DOI 10.1016/j.ncrna.2017.06.001
[46]   Long Non-coding RNAs: Mechanisms, Experimental, and Computational Approaches in Identification, Characterization, and Their Biomarker Potential in Cancer [J].
Chowdhary, Anshika ;
Satagopam, Venkata ;
Schneider, Reinhard .
FRONTIERS IN GENETICS, 2021, 12
[47]   Control of blood pressure and heart rate in patients randomized to epidural or general anesthesia for lower extremity vascular surgery [J].
Christopherson, R ;
Glavan, NJ ;
Norris, EJ ;
Beattie, C ;
Rock, P ;
Frank, SM ;
Gottlieb, SO ;
Meinert, CL ;
Parker, SD ;
Yates, H ;
Perler, BA ;
Williams, GM ;
Breslow, MJ ;
Rosenfeld, B ;
Taylor, D ;
Brasfield, B ;
Bourke, DL ;
Bezirdjian, P ;
Paul, S ;
VanNatta, M .
JOURNAL OF CLINICAL ANESTHESIA, 1996, 8 (07) :578-584
[48]   Transfer RNAs-derived small RNAs and their application potential in multiple diseases [J].
Chu, Xiaohua ;
He, Chenyang ;
Sang, Bo ;
Yang, Chaofei ;
Yin, Chong ;
Ji, Mili ;
Qian, Airong ;
Tian, Ye .
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
[49]   Bioinformatics Research Methodology of Non-coding RNAs in Cardiovascular Diseases [J].
Costa, Marina C. ;
Gabriel, Andre F. ;
Enguita, Francisco J. .
NON-CODING RNAS IN CARDIOVASCULAR DISEASES, 2020, 1229 :49-64
[50]  
Cui Qingyan, 2018, Oncotarget, V9, P34644, DOI 10.18632/oncotarget.26141